Penny Stocks Alerts for TOTALLY HEMP CRAZY, TapImmune, Root9b Technologies, EKSO BIONICS HOLDING, Propanc Health Group, and Dominovas Energy
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: TOTALLY HEMP CRAZY (OTCMKTS:THCZ), TapImmune (OTCMKTS:TPIV), Root9b Technologies (OTCMKTS:RTNB), EKSO BIONICS HOLDING (OTCBB:EKSO), Propanc Health Group (OTCMKTS:PPCH), and Dominovas Energy (OTCMKTS:DNRG).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
TOTALLY HEMP CRAZY (OTCMKTS:THCZ): By the end of last trading, the TOTALLY HEMP CRAZY (OTCMKTS:THCZ) shares earned 1.35% (or US$0.002) to US$0.135 with about 2.35 million shares exchanged hands for the session, compared to its average volume of 5.52 million shares. Since the start of the marijuana rush of 2014, it has become a regular thing for pot-stocks to surge with violent volatility upon the release of new praise or PR. Back to a few months ago, nobody would have predicted that the company will be able to manufacture such quantities of its flagship products, or aspire to up-list to the OTCQB. But the company’s latest pieces of PR were impressive which was about its claims and predictions. Is this company running promotion by penny stock promotor? Is there any insider trading in this company? Read full report Mere.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/062515A/THCZ/TOTALLYHEMPCRAZY.pdf
TapImmune Inc. (OTCMKTS:TPIV): By the end of last trading, the TapImmune (OTCMKTS:TPIV) shares lost 2.65% (or US$0.04) to US$1.47 with about 2.07 million shares exchanged hands for the session, compared to its average volume of 1.71 million shares. The company announced that Phase I patient data was analyzed in full and the results were encouraging. The trials involved women who had already gone the standard surgical and chemotherapy treatment. Those were then treated with a “multi-peptide HER2/neu vaccine”. After six months of revaccination there were 19 out of 20 patients who displayed a “robust” immune response and T-cell immunity, brought about by the vaccine. TPIV's previous announcement was that its biggest institutional investor, Eastern Capital Limited, exercised 5 million warrants and got as many common shares, priced at US$0.50 resulting in proceeds of US$2.5 million. The company stated the funds would go towards the commencement of Phase II trials. Is this company running promotion by penny stock promotor? Is there any insider trading in this company? Read full report Mere.
Read Full Report: http://www.Pennystocksinsiders.com/PR5/062515A/TPIV/TapImmune.pdf
Root9b Technologies Inc (OTCMKTS:RTNB): By the end of last trading, the Root9b Technologies (OTCMKTS:RTNB) shares soared 14.71% (or US$0.15) to US$1.17 with about 0.622 million shares exchanged hands for the session, compared to its average volume of 0.371 million shares. According to its latest 10-Q, the company has US$5 million cash on hand with total assets as US$23.4 million. Its latest quarterly revenues reached US$9.5 million. Those should be some impress numbers among the other OTC entities. But recently, while law firms are starting their investigations, and the people behind the company are trying to answer all the negative publicity, the stock is left to bear the brunt of the impact. Is this company running promotion by penny stock promotor? Is there any insider trading in this company? Read full report here.
Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
EKSO BIONICS HOLDING (OTCBB:EKSO):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/062515A/EKSO/EKSO.pdf
Propanc Health Group Corp (OTCMKTS:PPCH):
Dominovas Energy Corp (OTCMKTS:DNRG):
Read Full Report: http://www.Pennystocksinsiders.com/PR5/062515A/DNRG/DominovasEnergy.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit Pennystocksinsiders.com/disclaimers/index.php for details.
Reported on Jun 25, 2015
More Insider News ...